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 Abstract  
The ageing process is driven at the cellular level by random molecular damage which slowly accumulates 
with age. Although cells possess mechanisms to repair or remove damage, they are not 100% efficient 
and their efficiency declines with age. There are many molecular mechanisms involved and exogenous 
factors such as stress also contribute to the ageing process. The complexity of the ageing process has 
stimulated the use of computational modelling in order to increase our understanding of the system, test 
hypotheses and make testable predictions. As many different mechanisms are involved, a wide range of 
models have been developed. This paper gives an overview of the types of models that have been 
developed, the range of tools used, modelling standards, and discusses many specific examples of models 
which have been grouped according to the main mechanisms that they address. We conclude by 











Globally the proportion of older people (aged 60 or over) is rising and it has been estimated that it will 
nearly double from 12% in 2015 to 22% by 2050 (1). Furthermore, the “oldest-old” (aged 80 or over) group 
is estimated to triple in the same time period. The increase in the ageing population brings many 
challenges. Although many welcome the prospect of an increase in lifespan, this needs to be accompanied 
by an increase in healthy years rather than further years with disability and disease. Furthermore, there 
is wide variation in the health between older individuals with some 80 year olds having the same physical 
and mental capacity of many 20 year olds, whilst other individuals experience a decline in physical and/or 
mental capacity at much earlier ages (1). The reasons for this variability are complex and not understood. 
Therefore, there is an urgent need to increase our understanding of the underlying molecular mechanisms 
of the ageing process, so that the continual increase in the proportion of older persons in the population 
will be beneficial rather than detrimental to future societies.  
There are many theories of the biological causes of ageing which suggests that many different 
mechanisms contribute to the ageing process (2, 3). Kirkwood proposed that the underlying cause is 
mainly due to the accumulation of random unrepaired molecular damage over time. This eventually leads 
to cellular defects and tissue dysfunction resulting in increased frailty and age-related disease (2), as 
illustrated in Figure 1. Our cells possess quality control systems so that molecular damage can be 
recognised, repaired or removed. However, due to the energy requirements of these systems, somatic 
maintenance is not 100% efficient. All molecular components are susceptible to damage including DNA, 
proteins, lipids and organelles. Sources of damage may be intrinsic, such as reactive oxygen species (ROS) 
and reactive nitrogen species (RNS), or extrinsic such as UV light, irradiation and exposure to toxins. In 
terms of ageing, exposure to sources of damage over the human lifespan will vary between individuals 
and may in part explain the heterogeneity in how individuals age (4). Other contributing factors include 
genetics, epigenetics, diet, physical activity and chance. 
Many studies into the molecular mechanisms of ageing have focused on a particular theory such as the 
accumulation of somatic mutations, telomere shortening, protein damage, or mitochondrial dysfunction. 
However, in the late 1990s, it was realised that individual mechanisms cannot adequately explain the 
ageing process (5) and that we needed to consider the interactions between these different mechanisms 
(Figure 2). For example, damaged mitochondria produce more ROS which in turn leads to an increase in 
damage to all molecular components. This led to a network theory of ageing and the challenge of studying 
complex interactions motivated one of the first integrated mathematical models of ageing (5). Since then, 
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the advent of many new technologies and the ability to produce large volumes of experimental data 
necessitated the development of new tools to aid analysis and interpretation, leading to the emergence 
of systems biology approaches (6-8).  
Despite these advances, many experimental biologists remain unaware or sceptical of the use of 
computational models as a research tool. Therefore, in this review we give a brief explanation of the 
advantages of this approach to study complex biological systems. Firstly, models can be used to test 
hypotheses, and as every component and the interactions between components need to be clearly 
defined, it ensures that hypotheses are specific. Secondly, models can highlight gaps in knowledge, 
particularly during the model building process. Thirdly, models can make predictions which can then be 
tested experimentally and so help to advance our understanding of complex systems. Lastly, models can 
be used to test multiple potential interventions which would be very costly and time-consuming to do 
experimentally. 
The purpose of this review is to give an overview of mathematical and computational models that have 
been developed to examine the molecular mechanisms of ageing. We will start by describing some of the 
different computational approaches including types of models, modelling standards, software tools, and 
a summary of models that are publicly available from the BioModels database (9)(see section on 
modelling standards). We will then describe in more detail, some of the models which have been 
developed over the last 15 years of particular molecular mechanism including DNA damage, loss of protein 
homeostasis, mitochondrial dysfunction, dysregulation of cellular signalling pathways and epigenetic 
changes with age. Finally, we highlight some of the challenges and opportunities for future research in 
which we discuss integration of mechanisms and multi-scale modelling. 
COMPUTATIONAL APPROACHES 
Types of models  
The formalisation of a computational model begins with the evaluation of a series of fundamental 
questions. The first one addresses if the model is a static or a dynamic representation. Static models, 
commonly constructed through network inference algorithms, are primarily concerned with establishing 
statistical relationships between biological entities (10-13). Static models are commonly used in the 
identification of structural and functional patterns in large bodies of ‘Omics’ data (14-16) and for 
comparative studies (10). 
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Dynamic models aim to capture how the variables of interest evolve over time (17). This contrasts with 
the “snapshot-representation” of static models (15). However, dynamic models commonly require a 
comparatively larger number of parameters in order to capture behaviour along the time dimension (13). 
Because biological research inevitably concerns processes which occur over time, dynamic models are the 
most intuitive option to represent a biological system.   
The second fundamental question addresses the very nature of the process being modelled. Is it a discrete 
process or a continuous process? Alternatively, how well can a given process be approximated as being 
discrete or continuous whatever its underlying nature? A discrete process involves a series of identifiable 
states of the observable of interest, for example, the number of molecules in a cell or the number of fish 
in a pond. In a continuous process the solution space cannot be divided into discrete observables. For 
example, the joules of energy produced by the electron transport chain. 
The third fundamental question involves the role of randomness, or stochasticity, in the biological process. 
In a system which is not significantly affected by noise, deterministic models, which invariably show the 
same behaviour per given parameter set and initial conditions, can be used (18). Deterministic 
frameworks are commonly employed in the modelling of mechanical systems. In noisy systems, however, 
there is an intrinsic uncertainty in the relationship between parameters (18, 19). For example, whether a 
reaction occurs at a given moment in time depends on the probability of the encounter of the substrates 
in space. Stochastic models involve sampling from probability distributions to account for this uncertainty. 
The Gillespie algorithm (20), for instance, is a powerful method to model biochemical networks 
stochastically (19). This is because it captures the uncertainty associated with which reaction will occur 
next in a cell, and when exactly it will take place.  . 
The last fundamental consideration is whether the behaviour of the process modelled is dependent on 
the spatial dimension as well as the time dimension. An example of this would be the effect of intracellular 
gradients on cellular signalling (21) or localised niches in ecological studies (22). Figure 3 displays the 
conceptual classification of models and the common frameworks used in each classification. 
 Modelling tools  
There are a plethora of software tools that can be used to construct an in silico model of a biological 
system. These software tools fall into two broad categories 1) Commercial tools, which include packages 
such as Mathematica, Matlab and Maplesim and 2) Non-commercial open source software, which include 
software such as R, Python and C++. For experienced modellers the choice is dependent on personal 
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preference. However, fortunately for a biologist unfamiliar with modelling, the last decade has witnessed 
the development of several tools that are exceptionally user friendly. Examples include Copasi (23) and 
CellDesigner (24), both of which are underpinned by intuitive user interfaces that allow models to be 
assembled by the addition of reactions as word equations. The user then selects the type of kinetic rate 
law which is appropriate for each reaction from a drop-down menu. To run a deterministic simulation the 
software tool converts the reaction list to a set of coupled Ordinary Differential Equations (ODEs), which 
are numerically solved to provide model output. A stochastic model is assembled in a similar fashion, with 
rate laws replaced by propensity functions. The software tool then uses the Gillespie algorithm or one of 
its derivatives to perform stochastic simulations of the model. 
 Modelling Standards 
Regardless of the software tool that is utilized, systems biology models need to be accessible and 
straightforward to update and extend. This is particularly important for ageing, as our knowledge of this 
phenomenon continues to evolve. To facilitate this aspect of modelling, the computational systems 
biology community have developed a number of exchange frameworks. For instance, PySB is a framework 
for building mathematical models of biological systems using Python (25). However, the leading model 
exchange format is the systems biology markup language (SBML) (26). A large number of modelling tools 
support this framework, and a full list is provided on the SBML website 
(http://sbml.org/SBML_Software_Guide/SBML_Software_Summary). It is good modelling practice to 
submit an SBML encoded model for archiving in BioModels (9). BioModels is an online database 
(https://www.ebi.ac.uk/biomodels-main/) which stores the details of a model and assigns each model a 
unique identification number. Within this repository a model can be categorised as either curated or non-
curated. Curated models have been verified so results match its corresponding publication, while non-
curated models await this process. 
 Ageing themed models archived in BioModels 
There is a wide variety of ageing focused models stored in BioModels. We surveyed BioModels using the 
search terms “ageing” and “aging” and found 22 in the  curated and 6 in the non-curated section (Tables 
1-2). These models cover many aspects of molecular ageing. It is not possible to discuss each model, 
however within the context of this review a number of models are worth highlighting.  The model by Dalle 
Pezze et al. (27) is particularly noteworthy due to the close coupling of experimental work with model 
simulations. This model was able to consolidate experimental findings, which demonstrated inhibition of 
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ROS can inhibit the loss of mitochondrial membrane potential (BIOMD0000000582). The work of Geva-
Zatorsky et al. (28) encapsulates another important element of molecular ageing, the p53 system, while 
also juxtapositioning experimental work with computational modelling. The authors quantified the 
dynamics of fluorescently tagged p53 and Mdm2 over several days and found that isogenic cells in a 
homogenous environment behaved in a highly stochastic manner following DNA-damaging gamma 
irradiation and cells showed oscillations over several days. To explore this phenomenon in greater depth 
the authors used different mathematical models of the system to identify the source of the oscillations, 
which was revealed to be low-frequency noise in protein production rates, rather than noise in other 
parameters, such as degradation rates (BIOMD0000000154 to BIOMD0000000158). A more recent 
cellular model by Erguler et al. (29) uncovered three unique states of behaviour, low; high; and 
intermediate activity, which were correlated with stress adaptation, resistance, and the initiation of 
apoptosis (BIOMD0000000446). Collectively these examples give an overview of the diversity of cellular 
processes associated with ageing which have been modelled and are archived in BioModels. 
MODELS OF MOLECULAR MECHANISMS OF AGEING 
In this section we describe some of the previous models that have been developed to examine the 
molecular mechanisms of ageing. Many of these models focus on a particular mechanism and thus are 
categorised according to mechanism. However, due to the interaction of mechanisms some models that 
are placed in a particular category will also contain mechanisms from another e.g. a model of protein 
aggregation also incorporates the DNA damage response.  
DNA Damage and Repair  
 The accumulation of unrepaired DNA damage has long been proposed as a major causal factor in ageing 
(reviewed in (30)). DNA is susceptible to damage due to replication errors, intrinsic stress due to ROS and 
extrinsic stress such as UV light and irradiation. Most damage to DNA is detected and repaired via the 
DNA-damage response (DDR) involving ATM and p53 signalling. However, more complex lesions may 
remain unrepaired and accumulation of such lesions may lead to apoptosis, cellular senescence or cancer. 
Many models have examined the role of DNA damage on cellular senescence based on cells in culture 
such as human fibroblasts (31-34). These models did not include details of the molecular mechanisms 
involved in the DDR in which cellular signalling pathways involving ATM/ATR, p53 and p21 are activated, 
resulting in cell cycle arrest to allow for possible repair. DNA damage induced by irradiation causes levels 
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of p53 and its inhibitor Mdm2 to oscillate (35) and it was shown by mathematical models, that this 
behaviour was due to negative feedback loops in the system (28, 36-38). 
It has been shown experimentally that ROS acts in a positive feedback loop to activate and maintain cells 
in replicative senescence and this was confirmed by mathematical modelling (39). This model of DDR was 
an extension of a previous model of p53 dynamics (38), demonstrating the advantage of using SBML for 
model construction. In addition, the extended model showed that stochastic effects are important as it 
predicted that a small proportion of cells could escape cell cycle arrest which was then later confirmed 
experimentally (39). 
Models of DNA repair pathways have mostly been motivated by the need to improve cancer therapies 
(40, 41). Using experimental data of human fibroblasts that had been subjected to different levels of 
gamma irradiation, a stochastic model of the Non-Homologous End Joining (NHEJ) pathway showed the 
importance of redox regulation of the proteins Ku70 and Ku80 which form heterodimers that bind to the 
ends of DNA double strand breaks (42). The authors of this model, then went on to integrate their model 
with the DDR model previously developed by Passos et al. (39), producing the first model to incorporate 
both the DDR and DNA repair pathways (43). Although both the previous models were encoded in SBML 
and therefore very amenable to integration, the use of stochastic simulation for the integrated model 
proved infeasible. Therefore the model was converted to a rule-based system using BioNetGen. The 
model was used to examine the effect of irradiation on DNA damage repair and induction of senescence. 
Telomere shortening 
Telomeres are repetitive sequences of DNA that protect the ends of linear chromosomes. In human 
somatic cells, telomeres shorten with each cell division due to the end-replication problem and it has been 
suggested that telomere shortening explains why human diploid fibroblasts can only divide a limited 
number of times (known as the Hayflick limit) before a cell undergoes replicative senescence (44). The 
first mathematical models focussed on this process (45-48), but it was later shown experimentally that 
oxidative stress is an important factor, contributing to an increase in the telomere shortening rate by up 
to an order of magnitude (49). This additional factor was included in the models of Rubelj & Vondracek 
(50) and Proctor & Kirkwood (51). The latter model also included free radical species as a model parameter 
and helped to explain why cells cultured under conditions of increased oxidative stress have reduced 
replicative capacity. The models of telomere shortening so far described assumed that either a critically 
short telomere or a subset of short telomeres triggered replicative senescence. However, it has been 
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shown that cells stop dividing over a wide range of telomere lengths. Since telomeres are protected by 
various telomere-binding proteins and the formation of t loops, it has been hypothesised that the 
disruption (uncapping) of these loops may be the actual trigger. The model by Proctor & Kirkwood (51) 
was adapted so that the trigger for senescence was an uncapped telomere, with the assumption that the 
probability of uncapping increases as telomere length shortens, and this model provided a better fit to 
the experimental data (52). Rodriguez-Brenes & Parkin (53) modelled the biophysics of the t loop whereby 
the t loop represented the capped state and also included telomerase, an enzyme that elongates 
telomeres in non-somatic cells such as germ-line cells. Telomere shortening alone is unlikely to account 
for the observed heterogeneity in the doubling potential of cells from within the same clone (54). This 
was elegantly shown by an integrated model which incorporate not only telomere shortening but also 
nuclear somatic mutations and mitochondrial damage (55). On a rather different tack, Aviv et al. (56), 
proposed a model linking telomere dynamics with successful versus unsuccessful ageing based on 
evidence that individuals with short telomeres have a higher risk of atherosclerosis (57).  
Loss of protein homeostasis  
Protein homeostasis is crucial for cellular function and is maintained by quality control systems involved 
in protein synthesis, folding, and refolding (reviewed in (58)). Evidence for the role of damaged proteins 
in ageing is the observed increase in oxidised proteins with age in brain (59). Proteins are susceptible to 
oxidative damage which results in either conformational or covalent changes. Most forms of covalent 
damage are irreversible and so proteins with such damage need to be degraded in order to prevent their 
accumulation and cross-linking. Conformational damage may be repaired by molecular chaperones which 
bind to exposed hydrophobic surfaces and assist in refolding. However, it has been proposed that the 
chaperone system becomes overwhelmed with age leading to a further increase in damaged or misfolded 
proteins (60). 
Molecular chaperones 
Molecular chaperones are upregulated during stress by a feedback mechanism involving the transcription 
factor Heat Shock Factor-1 (HSF-1) and the molecular chaperone Hsp90 (61). Normally, HSF-1 is kept in an 
inactive monomeric state by binding to Hsp90. However, under stress conditions, there is an increase in 
misfolded proteins which also bind to Hsp90 releasing HSF-1 which can then trimerise, translocate to the 
nucleus and become transcriptionally active. This results in an increase in molecular chaperones which 
can then assist in refolding the denatured proteins. Several models of the heat shock response in response 
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to elevated temperature have been developed which have used a deterministic approach e.g. (62, 63). 
However, to date, only two models have included the effects of ageing on the system (64, 65). Proctor et 
al. (64) included a mechanism for an increase in misfolded protein with age as a result of increased 
oxidative stress and also examine the effect of damage to the molecular chaperones themselves. Since 
damage is a random process, they used stochastic simulation. The model showed that the chaperone 
system was able to maintain homeostasis under conditions of mild or transient stress. However, chronic 
stress eventually led to a point when the balance between molecular chaperones and misfolded proteins 
could not be maintained so that misfolded proteins bound together to form aggregates. This model was 
extended to include the chaperone Hsp70 and its role in apoptosis which allowed for the possibility that 
cells with high level of misfolded proteins may undergo programmed cell death (65). 
Protein degradation pathways 
Proteins are constantly turned over in the cell although there is large variability in the half-lives of different 
proteins. There are two main pathways for protein degradations, the autophagic system and the 
proteasomal system. Both systems may eliminate damaged proteins. Oxidised proteins may be eliminated 
by 20S proteasome (66) or the ubiquitin/proteasome system (UPS) (67), but, their efficiency declines with 
age leading to a build-up of damaged protein especially in post-mitotic cells (58). It has been hypothesised 
that damaged proteins overwhelm the capacity of proteasomes and that coupled with age-related 
damage to the proteasome results in a self-amplifying cycle of impairment (68). Previous mathematical 
models of protein degradation by the proteasome have examined the kinetics of peptide hydrolysis 
(reviewed by (69)) but very few models exist that examine the role of protein degradation in the context 
of ageing. A model of the ubiquitin-proteasome system which incorporated normal homeostasis and age-
related decline was developed by Proctor et al. (70). In addition to the effects of an increase in damaged 
and aggregated protein, depletion of ubiquitin pools was shown to also contribute to the decline in 
protein homeostasis with age. 
The autophagic system includes macroautophagy and chaperone-mediated autophagy (CMA), which both 
functionally decline with age (71). CMA is upregulated by oxidative stress in order to degrade damaged 
proteins (72). It is inhibited by mutant proteins such as modified α-synuclein (73). There is crosstalk 
between autophagy and apoptotic pathways and a mathematical model was used to examine how levels 
of stress determine the switch between these two outcomes (74). Despite the lack of models on the 
effects of ageing on protein degradation, several models of protein aggregation in age-related 
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neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), also include 
protein degradation pathways and will be discussed below. 
Protein aggregation 
Many models of protein aggregation in age-related neurodegenerative disorders have been developed 
(75-82). Some of the models focus just on the dynamics of the aggregation process (reviewed by (83)), 
whereas others incorporate other processes such as protein degradation (78, 84, 85), chaperones (86),  
neuroinflammation (87, 88), the DNA damage response (89), oxidative stress (77) and apoptotic pathways 
(79). The aggregation of alpha-synuclein is a key factor in PD. It is degraded by macroautophagy, CMA or 
the proteasome and is susceptible to modifications which make it prone to aggregate. This complex 
system has motivated several models which have incorporated both autophagic and proteasomal 
pathways to examine the mechanisms involved in alpha-synuclein aggregration (77, 78, 85, 90). Raichur 
et al. (77) also included oxidative stress in their model and showed that alpha-synuclein aggregation 
increased with stress supporting the hypothesis that an increase in oxidative stress may precipitate 
sporadic PD (reviewed by (91)). 
Many models of the aggregation process in AD have also been developed. Two different aggregates are 
implicated, namely amyloid plaques and tau tangles, however, the majority of models focus only on the 
aggregation of amyloid beta e.g. (76, 81, 87, 88). Surprisingly, very few models consider the aggregation 
of tau despite many unanswered questions regarding the relative contribution of plaques and tangles to 
disease progression, and the mechanisms which link the two aggregation processes. The only models that 
we are currently aware of are all from one group (82, 89) and further modelling suggested that there is a 
cycle of events which can explain why plaques, tangles or both are seen in the ageing brain (92). 
The majority of models examine the aggregation process based on short timescales based on in vitro 
cellular models. Computer simulation time also limits timescales for stochastic models. However, by 
making simplifying assumptions it was possible to simulate aggregation of amyloid-beta over a 100 year 
period (81) and to use this model to test intervention strategies.  
Although mitochondrial function has also been shown to play an important role in age-related 
neurodegeneration, there are currently no models of protein aggregation that explicitly include 
mitochondria. Since mitochondrial dysfunction leads to an increase in oxidative stress, impaired energy, 
and inhibits autophagy, linking models of mitochondrial damage and ROS (see next section) and protein 
aggregation would provide new insights into the causes of age-related decline in protein homeostasis. 
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Mitochondrial damage and ROS  
Ever since Harman expanded his free radical theory of ageing (93) to include mitochondria (94), the main 
site of ROS production in cells, abundant evidence has amounted on the association of both increased 
ROS levels and dysfunctional mitochondria with age and age-related diseases (95-99). The complexity of 
mitochondria as an organelle and the short-lived nature of ROS molecules have resulted in experimental 
difficulties in dissecting a potential causal role in the driving of the ageing process (100-102). However, 
computational modelling efforts have laid some important conceptual and mechanistic groundwork over 
which experimental methodologies may build upon despite their current limited resolution. 
Kirkwood and Kowald (103) have made use of a variety of models to conceptually establish some 
phenomena that could be causative of the observed phenotypes of mitochondrial dysfunction. They 
demonstrated how increased antioxidant expression in mitochondria is unlikely to reduce damage to 
mitochondrial DNA (103). They furthermore discriminated between different potential driving 
mechanisms of mitochondrial heteroplasmy, where a faster transcription was established to be a source 
of selective advantage for mitochondrial DNA mutants rather than random drift alone or a smaller genome 
size (104, 105). Another example of laying conceptual groundwork through computational modelling 
comes from the work of Lawless et al. (106). The authors establish that the continuous increase in ROS 
levels seen in cultured cells undergoing senescence can be explained by a stochastic entry of individual 
cells into a senescent state with a time-invariant ROS level.  
Computational models have also been used to formalise mechanistically the homeostatic mechanisms 
regulating both ROS levels and mitochondrial function (107-110). Gauthier et al. (111) developed a 
comprehensive computational model that captures mitochondrial ROS production in different 
mitochondrial energetic states as determined by pacing frequency. Their model established a link 
between dysfunctional calcium handling and increased ROS production by the mitochondria due to the 
elevated cytosolic sodium levels seen in aged cardiomyocytes (111). Whilst Passos et al. used 
computational modelling to prove the driving of the cellular senescence state involves ROS production by 
dysfunctional mitochondria (39), Dalle Pezze et al. (27) constructed the first comprehensive model of 
cellular senescence. They reported an increased stochasticity and reduced network sensitivity to both 
endogenous signals and exogenous treatments. These higher-order observations on network-wide 
changes during senescence are coherent with the accepted notion on ageing being a holistic, multi-
mechanism process (6, 112). 
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Mitochondrial dynamics  
Ageing is associated with the accumulation of damaged mitochondria, which may be due to a decline in 
mitochondrial turnover. There have been a number of computational models which have investigated this 
phenomenon. For instance, the model developed by Kowald and Kirkwood (113) was used to demonstrate 
that damaged mitochondria have impaired energy metabolism. The model also showed that as a 
compensatory mechanism, mitochondria have a reduced rate of degradation, which results in clonal 
expansion of damaged mitochondria. This theoretical work was able to consolidate experimental evidence 
that aged muscle fibres often contain a reduced number of mtDNA mutant types. Simulations also 
suggested that cellular division can rejuvenate and stabilize the mitochondrial population, in accordance 
with experimental data that suggests that mitochondrial damage accumulates faster in post-mitotic 
tissues than mitotically active tissues. Importantly, the authors suggest that in vitro studies of ageing 
underestimate the contribution of mitochondrial-related cell degradation to cell ageing (113). This finding 
is plausible as experimental evidence has indicated that dietary restriction may increase mitochondrial 
turnover (114). Modelling has also been used to investigate the interaction between caloric restriction 
and mitochondrial metabolism. For instance, Miwa et al. (115) investigated dietary restriction, using 
computational modelling to support their experimental findings. It was estimated that the liver 
mitochondria of mice had a significantly reduced median half-life following 3 months dietary restriction, 
when compared with controls (1.16 days vs. 1.83 days), thus supporting the hypothesis that dietary 
restriction may promote mitochondrial turnover (115). 
Mitochondria have been observed to undertake a complex fusion-fission cycle (116) and computational 
modelling has also helped improve our understanding of this process. Kowald and Kirkwood (117) used 
mathematical modelling to argue that fusion is necessary, due to the migration of mitochondrial genes to 
the nucleus, and that mitochondrial fusion is the underlying mechanism regulating the accumulation of 
mitochondrial mutants with age, while fission may ameliorate this accumulation (117, 118). Mouli et al. 
(119) determined that during conditions of elevated damage, the selectivity of a fusion event is 
particularly important as it allows an increase in the frequency of fusion without comprising damaged 
content removal. The mathematical model developed by Tam et al. (120) demonstrated that low fission-
fusion reduced mtDNA mixing resulting in an uneven distribution of mutant mtDNA within mitochondria 
and increased stochasticity from a mitophagic event. Consequently, clonal expansion of mutant 
mitochondria became more frequent. The model also predicted that protective retrograde signalling  
depended on fusion-fission efficiency (120). The mitochondrial infectious damage adaptation (MIDA) 
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model describes that the decline in the rate of fusion-fission cycling may reflect a systemic adaptation to 
prolong lifespan by reducing damage spread (121). 
Dysregulation of cellular signalling  
Target of rapamycin (TOR) signalling   
The target of Rapamycin (TOR) protein is a protein kinase which exists in two distinct multi subunit 
complexes, mTORC1 and mTORC2 and is capable of sensing nutrient and amino acid availability, growth 
factor and hormonal signals (122-124). Depending upon the state of these inputs the TOR signalling 
pathway regulates cell growth, autophagy, protein production as well as energy stores around the body. 
With age numerous proteins within the mTOR network can become dysregulated (125, 126). Numerous 
groups have used computational models to attempt to map the kinetics of the system and identify 
intervention strategies to manage the dysregulation of the network in age related disorders (127, 128). 
Kholodenko (129, 130) has used multiple mathematical models to investigate cancer biology. Kholodenko 
investigated the response of feedback loops within the mTOR network to different inhibitors gaining 
insight into the dynamics of the system under different perturbations (131, 132). They along with other 
groups, have demonstrated that dynamic modelling could be used to understand the effect on both mTOR 
and related network proteins following a single targeted intervention of a protein within the mTOR 
network. The main focus of these studies has been on AKT and PTEN two proteins regularly found to be 
dysregulated with age (130, 133). Mathematical modelling has provided a framework to integrate mTOR 
to various other cellular processes including cellular senescence (27). Dalle Pezze et al. (27) integrated a 
dynamic model of the mTOR network model with a dynamic model of cellular senescence. They identified 
potential new interventions for attenuating cellular senescence. Due to the strong links between mTOR 
signalling and insulin signalling there have many efforts made to create mathematical models of the two 
combined especially in the area of type 2 diabetes mellitus (T2DM) (134, 135). Cedersund et al. (136) used 
such a model to identify a feedback loop between mTORC1 and insulin signalling which is reduced in 
T2DM.  
 
FOXO signalling  
The family of transcription factors known as Forkhead Box O proteins (FOXO) are conserved throughout 
species from C. elegans to humans and it has long been known that modulation of these proteins can 
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increase or decrease lifespan (137, 138). Whilst FOXO proteins play a key role in ageing there are very few 
mathematical models focusing on their role in this process. Dynamic models that do focus on ageing often 
include FOXO proteins and their interactions with the mTOR network as part of a model (139, 140). In 
their model of cellular senescence, Dalle Pezze et al. (27) modulated the levels of FOXO3A activity and 
assessed the reaction of mitochondrial mass following this activation. The authors showed that an 
increase in FOXO3A activity reduced mitochondrial size and reduced DNA damage indicating that FOXO3A 
modulation could play a key role in cellular senescence (27). Work carried out by Smith and Shanley (141) 
has modelled in depth the post-translational modifications on FOXO proteins. Building on this, they 
investigated the effect of ROS on FOXO activation and translocation (141, 142). Their mathematical model 
showed that at low oxidative stress, FOXO upregulated the antioxidant defence, whilst under chronic 
oxidative stress, it is down-regulated. 
Insulin/IGFsignalling  
The insulin and insulin-like growth factor IGF signalling (IIS) pathway plays an important role in energy 
metabolism and growth. Reduced IIS, enhanced insulin sensitivity, and reduced plasma IGF-1 have been 
associated with longevity in invertebrate and murine species (143, 144). To examine the metabolic 
dynamics associated with insulin resistance (IR), Nogiec et al. (145) developed a flux balance model. This 
model suggested the metabolic phenotypes associated with IR are likely due to the dysregulation of 
several key nodes rather than a single gene defect. The model also demonstrated that dual knockdown of 
pyruvate dehydrogenase and lipid uptake or lipid/amino acid oxidation reduced ATP synthesis, TCA cycle 
flux and metabolic flexibility (145).   
Disruptions to the IGF pathway are also heavily implicated in the maintenance of health-span. For 
instance, the IGF pathway is highly activated in ovarian cancer. To investigate the impact of the IGF system 
on cell proliferation, Tian and Kreeger (2014) created a kinetic model, which suggested the binding of IGF-
binding proteins (IFGPBs) to IGF-1 significantly reduced IGF-1 mediated proliferation, and that treatment 
to block IGF1-IGF1R binding would be more effective at inhibiting cell proliferation, than neutralising IGF1 
(146). Additionally, the insulin-TOP-MAPK network model developed by Nijout and Callier (139), which 
correctly demonstrated that MAPK, active PI3K, and GLUT4 responded in a dose dependent manner to 
insulin, demonstrated that at lower insulin levels PTEN-knockout increased protein synthesis, and 
increased insulin sensitivity by GLUT4 activation, consistent with PTENs role as a tumour suppressor. 
 TGF-β signalling  
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Knowledge of TGF signalling has benefited from expanding on already developed models. Vilar et al. (147) 
originally developed a concise model to represent the pathway . This model showed receptors as not only 
transducers of signal but key modulators of a downstream TGF-β response. Shortly after, Schmierer et al., 
(148) created two models with altered SMAD phosphorylation and nucleocytoplasmic dynamics.  
Attempting to match both of these models to their experimental data highlighted the importance of 
correct SMAD dynamics, as only one of the models could accurately fit the data. Zi et al., (149) realised 
the importance of including the dynamics of both receptors and SMADs, and so created a more 
comprehensive model that took elements from both Schmierer et al. (148) and an earlier model 
developed by Zi et al. (150), as well as including TGF-β depletion and ligand dynamics. Wegner et al.(151) 
expanded on elements of all these previous models to included more detailed negative and positive 
feedback mechanisms, allowing them to replicate oscillations seen in experimental data. 
TGF-β is known to signal through different type 1 receptors resulting in downstream phosphorylation of 
either SMAD2/3 or SMAD1/5/8, depending on the particular SMAD phosphorylated TGF can mediate 
completely different gene expression signatures. The previous models only examined SMAD2 dynamics, 
however a recent model also incorporated SMAD1/5/8 and showed that the SMAD7 mediated crosstalk 
between the two SMAD pathways is important for determining cellular responses (152). How SMAD 
signalling changes as we age may be important in the development of a range of diseases. A model 
detailing the changes in TGF-β receptors over time, and the consequential changes in gene expression 
showed that this contributes to osteoarthritis development during ageing (153). Understanding the 
receptor dynamics as well as how they change with age is of great importance for many diseases and 
computational modelling could be of paramount importance to understanding this pathway.  
NF-κB signalling  
The Nuclear factor-κB (NF-κB) signalling pathway mediates the expression of genes which influence a 
range of biological processes including; immunity, inflammation, cell differentiation, and apoptosis, which 
are activated by a range of stimuli, including infection, ROS, and DNA damage (154, 155). Elevated NF-κB 
has been associated with the onset of several age-related diseases, while inhibition of NF-κB has been 
linked with a delayed onset of age-related disease in murine models (156). There are a large number of 
models representing different aspects of NF-κB signalling e.g. (157, 158). Pogson et al. (159)  used agent 
based modelling to predict an important role for IκBα-actin interactions, which may be important for NF-
κB-IκB complex formation and negative feedback (159, 160). Gong et al. (161) modelled the HMGB1-p53-
NFkB-Ras-Rb network and demonstrated that knockout of A20 destroyed the IκB/NF-κB negative feedback 
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loop and liberated NF-κB. Elevated NF-κB increased the concentration of Cyclin E, which has been 
associated with cancer proliferation (161). By using fuzzy logic modelling, Kriete et al. (162) describe that 
a reduction in NF-κB also improves mitochondrial and biosynthesis functions rapidly. It is important to 
note that none of these models have explicitly modelled ageing. Chronic, low-grade inflammation is an 
important contributor to human ageing and has been termed inflammaging (163). Thus, in the future it 
would be worthwhile adapting or modifying these models to explore this phenonemon. 
Cytokine signalling   
Cytokines are critical in the regulation of inflammatory responses. Their interactions are complex and how 
they change with age is important in a number of diseases. One of the major cytokines is Interleukin-1 (IL-
1) and its importance is reflected in the amount of work that has been done on modelling its interactions 
and changes in IL-1 signalling with age. Proctor et al. (164) developed a model that detailed the 
interactions between IL-1 and oncostatin M (OSM), and explored how their synergy leads to excessive 
cartilage destruction. The group also incorporated IL-1 into a model of cartilage ageing with multiple other 
cytokines, to show how changes with age can lead to the development of conditions, in this case cartilage 
breakdown resulting in OA (153). 
Circadian rhythms can be important in the inflammatory response, changing the level and effect of 
cytokines, as modelled by (165). They showed how the levels and effects of IL-1 amongst others can 
change over a 24 hour light/dark cycle. Incorporating how these rhythms change in an ageing model could 
help explain the role of cytokines in ageing and age-related diseases. Cytokines, of course, encompass 
much more than just IL-1, which is why Baker et al. (166) created a model attempting to replicate an 
overview of all cytokine interactions in rheumatoid arthritis. Rather than having all cytokines as a separate 
species in the model they created a two variable model encompassing all cytokines into pro or anti-
inflammatory stimulus. Using only these two species they showed a range of possible behaviours that 
demonstrated how disease states can develop over time. 
Parathyroid hormone signalling   
Bone remodelling is vital for maintenance of healthy bone as it allows removal of old bone, as well as 
repair from micro-fractures making sure it remains strong and healthy throughout life. This process was 
modelled extensively in Lemaire et al. (167), showing a vital role for parathyroid hormone (PTH). Matching 
simulations to experimental data they showed how ageing effects (such as oestrogen deficiency) can alter 
bone remodelling, even in conjunction with currently used or potential drug interventions. 
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 Administration of PTH is used to combat bone loss but it must be applied intermittently as constant 
exposure can cause bone loss. A computation model was developed to examine the mechanisms of the 
opposing effects of PTH (168). The model demonstrated how PTH could cause both bone growth and loss, 
leading to a novel hypothesis that it was mainly due to the  effect of PTH  on osteoclast (cells which remove 
bone) activation. Expanding on this, another computational study looked at the effect of PTH and loading 
on ageing related bone loss (169). The importance of precise PTH cycles in addition to regular loading is 
demonstrated in this model. In addition, the model was used to examine the effect of PTH treatments 
with age, their results agreeing with the conclusion in (168). 
Geometric regulation has not been incorporated into these models. However, Pivonka et al. (170) 
demonstrated its importance in bone remodelling and early development of osteoporosis, suggesting any 
future models of age related bone loss should be aware of its effect on PTH and loading.  
DNA methylation dynamics and computational modelling    
There is growing evidence that DNA methylation status and intrinsic ageing are inexorably correlated.  
This view is supported by a wealth of experimental evidence. Most strikingly, the computational work of 
Horvath (171) who used methylation data sets to pinpoint an “epigenetic clock” whose time is governed 
by methylation changes within several hundred CpGs, a CpG being a dinucleotide consisting of a 
deoxycytidine followed by a deoxyguanidine, with the “p” indicating the phosphate group between these 
nucleotides. More recently others such as Curtius et al. (172) used methylation data and Bayesian 
modelling to estimate patient-specific disease onset times in what they suggest is a  “molecular clock 
which can infer specific tissue age in patients with Barrett’s Oesophagus”. These findings are intriguing as 
epigenetic mechanisms such as DNA methylation are modifiable and offer the possibility that ageing may 
be reversible or at very least  malleable.  However, the biochemical and molecular processes involved in 
the regulation of DNA methylation events are multifaceted and exceptionally complex. Gaining a deeper 
understanding of these processes is challenging. For instance, the enzyme mediated events which are 
responsible for the addition and removal of methyl groups to CpG dinucleotide intersect with folate one 
carbon metabolism (FOCM) (173). Moreover, it has been shown that both FOCM and DNA methylation 
are affected by other factors associated with ageing. For instance, both FOCM and DNA methylation are 
affected by oxidative stress (174-176). In addition, the activity of DNA methyltransferase 1, the key 
enzyme responsible post replicatively for transferring methyl groups to the DNA molecule has been shown 
to be influenced by sirtuin-1 (SIRT1) (177). In recent years a number of models have been used to 
mechanistically represent DNA methylation, and these could be adapted to focus on crosstalk between 
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DNA methylation and other elements of cellular ageing. For example, a recent model that was constructed 
using partial differential equations was able to fully represent the full suite of DNA 
methylation/demethylation reactions and was used as a tool for predicting haematological malignancies 
(178). More specific to intrinsic ageing, Przybilla et al. (179) used a stochastic model to explore age-related 
changes in DNA methylation within stem cells and simulations suggesting homing at stem cell niches 
retarded epigenetic ageing. 
MicroRNAs and Modelling 
MicroRNAs (miRNAs) are evolutionarily conserved post-transcriptional non coding gene regulators, which 
operate by inducing mRNA degradation or translational repression in a site sequence specific manner 
(180). Mathematical modelling has played a unique role in helping to unravel the dynamics which 
underpins their behaviour. Specifically modelling has helped to identify feedback and feedforward loops 
in miRNAs mediated networks and has revealed interactions between miRNAs during the regulation of 
genes (reviewed in (181)). Although models have mainly focused on cancer, many of the biological 
processes that have been modelled have also been implicated with intrinsic ageing. For instance, Lai et al. 
(182) used a computational model based on the p53/Sirt1 signalling pathway to explore the regulatory 
effect of miR-34a on p53 through its impact on Sirt1. This model demonstrated inhibition of p53 activity 
due to Sirt1 upregulation could be mitigated by upregulating miR-34a expression. Given the proposed role 
of Sirt1 in aging, it would be worthwhile adapting a model such as this to explore this relationship further 
to assess the implications for ageing. Models have also explored other aspects of cellular ageing. For 
example, the model by Xue et al. (183) integrated miR-21 and miR-146 expression into a signalling 
pathway to create a mode of the inflammatory response. Output from the model showed that negative 
feedback provided by miR-21 modulated the oscillatory behaviour of NF-κB and IL-6 activity. In addition, 
the model demonstrated negative feedback by miR-146 dampens the oscillations of NF-κB and IL-6, 
indicating these are mediators of this process.  
Tissue regeneration  
A decline in tissue regeneration is another important factor in cellular ageing and is considered to 
be mainly due to a depletion or loss of function of stem cells and altered intercellular 
communication (184, 185). There are multiple molecular mechanisms contributing to this decline 
including an accumulation of DNA damage, telomere shortening, epigenetic changes and loss of 
protein homeostasis. These mechanisms cause cellular damage and lead to cellular responses, 
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which initially reduce the damage but if activated chronically can produce deleterious effects 
themselves  (184). Finally, the chronic activation of cellular responses to damage leads to the 
decline in tissue function due to stem cell exhaustion and disruption of intercellular signalling 
(184). For example, muscle regeneration after injury requires differentiation of satellite cells but 
with age there is a gradual decline in the response to damage signals. As a multitude of 
overlapping processes are involved in tissue regeneration, computational modelling is  an ideal 
tool for investigating their interactions and it offers the potential of helping to isolate those 
mechanisms which are fundamental to this phenomenon. To date a number of worthwhile models 
have been developed which touch on various aspects of this biological system. For instance, stem 
cell dynamics have been modelled ubiquitously, however to our knowledge only two models of 
this nature have specifically centred on ageing.  These are the models by Przybilla et al.(179) 
which examined the role of age-related DNA methylation changes (as discussed previously), and 
Duscher et al.(186) which modelled the effect of ageing on MSC population dynamics and showed 
that an age-related depletion in a sub-population of progenitor cells impaired the formation of new 
blood vessels. If these models and elements of the other models we have discussed could be 
integrated together, with processes such as disrupted intracellular communication and the 
concomitant increase in the inflammatory response due to the secretion of pro-inflammatory 
cytokines by senescent cells, together with the activation of NFκB, this would result in a 
comprehensive model. This model would be more than capable of representing and exploring the 
dynamics of tissue regeneration in greater depth.  In the next section we will discuss the technical 




Opportunities and challenges for the future 
Integration of mechanisms  
Despite the insights that computational modelling efforts have contributed to understanding of ageing , 
in silico representations of biological systems are constrained to specific experimental models, specific 
canonical pathways or a specific stimulus. However, recent efforts have taken on the challenge to expand 
the models to include crosstalk and multiple input stimuli in an attempt to more faithfully recreate the 
complex nature of the underlying signalling networks (27, 164, 187-189). 
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The practice of model integration is not uncommon. For example, Markevich et al. (190) expanded a 
previously developed model of the electron transport chain and Gauthier et al. (111) combined a model 
of mitochondrial metabolism with an antioxidant model to produce a comprehensive virtual 
mitochondrion. However, it has only been relatively recently that the tools have become available (191, 
192) to standardize and automate the model integration process through the identification of shared 
model variables via semantic analysis of SBML (193). It is worth noting that most of such automated 
methods of model integration operate for networks of the same scale (e.g. subcellular pathways) and of 
the same mathematical framework (e.g., ODE models). Integrating models beyond scales and 
computational frameworks is an avenue of current work and challenges (194). 
The computational power needed to cost-effectively simulate larger integrated models is a major hurdle 
against the effort to construct more complex networks. An elegant example of how this problem can be 
addressed can be seen in the abstraction of the mTOR network by Dalle Pezze et al. (27). The authors used 
a previously developed model of mTOR and abstracted it to a network motif whilst retaining the key 
observables to encode system behaviour and then integrated it with abstracted representations of the 
DNA damage and stress responses. The increasing number of in silico models becoming available will offer 
a greater opportunity for model integration in response to new findings in the scientific literature.  
Multi-scale models  
From our discussion of ageing, it is clear it is an exceptionally complex process with a multitude of 
overlapping mechanisms and networks. Despite this, many of the models we have discussed centre on 
very specific processes, however, as of yet there is no fully integrated model which encapsulates all the 
current knowledge about ageing. It is imperative this issue is addressed, as a fully integrated model will 
lead to a deeper understanding of ageing (195, 196). To do this, several computational challenges need 
to be addressed. Firstly, the factors associated with ageing operate over widely different timescales and 
in many instances it is appropriate to assume spatial homogeneity. For example, when modelling a 
biochemical/physiological network, a deterministic based ODE model is suitable. However, this 
assumption is not always valid, especially when considering molecular systems where noise is an issue 
due to the inherent statistical mechanical fluctuations in the binding and discrete dynamics of the 
molecules involved in the reactions. Therefore, stochastic models are more suited to this type of system. 
It is necessary to develop computational approaches capable of integrating these theoretical approaches 
in a meaningful way. Recently, several worthwhile examples of hybrid computational approaches have 
been developed to address this problem. In an eloquent hybrid model of cell cycle regulation, Singhania 
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et al. (197) utilized continuous ODEs and discrete Boolean networks. The model tracked cyclin levels by 
using piecewise linear differential equations, with cyclin synthesis and degradation modulated by discrete 
variables. More specific to ageing, Kriete et al. (162) developed a rule-based cell systems model. This 
model of cellular ageing incorporated the mTOR pathway coupled with mitochondrial homeostasis and 
the NF-κB pathway. In addition to these examples, the computational systems biology community has 
proposed several solutions to the challenge of multi-scale modelling. Sütterlin et al. (198) developed a 
novel software workflow (EPISIM) for the semantic integration of SBML encased models. More recently, 
Somogyi et al. (199) developed libRoadRunner a Python based application which supports large-scale 
problems for SBML encoded models, including multi-module modelling. Continued progress of this nature 
in the field of computational biology will be a significant benefit to those using computational models to 
investigate the complexities of ageing.    
Conclusion  
In this article we have given an overview of the currently available models which are relevant for 
increasing our understanding of the molecular mechanisms of ageing. The majority of models focus on 
particular mechanisms and many of the earlier models were constructed in such a way as to make it 
difficult to modify or integrate. With the advent of new systems biology tools and modelling standards 
such as SBML, computer models have become much more adaptable and there is now a very useful pool 
of models available. This will hopefully allow for more integrative models to be constructed in the future, 
as it is now clear that biological ageing is not driven by an individual process, but involves a complex 
interplay of many different mechanisms.  
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Table 1 Curated models with an ageing theme archived within BioModels 
Model BioModel ID 
A quantitative model of the generation of N(epsilon)-
(carboxymethyl)lysine in the Maillard reaction between 
collagen and glucose. 
BIOMD0000000053 
Modelling the actions of chaperones and their role in 
ageing. 
BIOMD0000000091 
Alternative pathways as mechanism for the negative 
effects associated with overexpression of superoxide 
dismutase. 
BIOMD0000000108 
A mathematical model of glutathione metabolism. BIOMD0000000268  
Experimental and computational analysis of 
polyglutamine-mediated cytotoxicity. 
BIOMD0000000285  
Feedback between p21 and reactive oxygen production 
is necessary for cell senescence. 
BIOMD0000000287  
A mathematical model of the unfolded protein stress 
response reveals the decision mechanism for recovery, 
adaptation and apoptosis. 
BIOMD0000000446 
  
In vivo and in silico analysis of PCNA ubiquitylation in 
the activation of the Post Replication Repair pathway in 
S. cerevisiae. 
BIOMD0000000475 
Feedback motif for the pathogenesis of Parkinson's 
disease. 
BIOMD0000000558  
A model of the coupling between brain electrical 
activity, metabolism, and hemodynamics: application to 
the interpretation of functional neuroimaging. 
BIOMD0000000570  
Simulated interventions to ameliorate age-related bone 




Modelling the checkpoint response to telomere 
uncapping in budding yeast. 
BIOMD0000000087  
Modelling the actions of chaperones and their role in 
ageing. 
BIOMD0000000091  
An in silico model of the ubiquitin-proteasome system 
that incorporates normal homeostasis and age-related 
decline. 
BIOMD0000000105  
Explaining oscillations and variability in the p53-Mdm2 
system 
BIOMD0000000188  
Explaining oscillations and variability in the p53-Mdm2 
system. 
BIOMD0000000189  
A whole-body mathematical model of cholesterol 
metabolism and its age-associated dysregulation. 
BIOMD0000000434  
Aggregation, impaired degradation and immunization 
targeting of amyloid-beta dimers in Alzheimer's disease: 
a stochastic modelling approach.  
BIOMD0000000462  
Investigating interventions in Alzheimer's disease with 
computer simulation models.  
BIOMD0000000488 
  
Mathematical modelling of cytokine-mediated 
inflammation in rheumatoid arthritis. 
BIOMD000000054 
Oxidative changes and signalling pathways are pivotal in 
initiating age-related changes in articular cartilage. 
BIOMD0000000560 
  
Dynamic modelling of pathways to cellular senescence 








Table 2. Non curated models with an aging theme 
Model Bio Models ID 
Mathematical modelling for the pathogenesis of 
Alzheimer's disease.  
MODEL1409240001 
Modelling of calcium dynamics in brain energy 
metabolism and Alzheimer's disease. 
MODEL1409240003  
To senesce or not to senesce: how primary human 
fibroblasts decide their cell fate after DNA damage. 
MODEL1505080000 
Modelling the response of FOXO transcription factors to 
multiple post-translational modifications made by ageing-
related signalling pathways (Pathways A-C) 
MODEL1112260000: Pathway A 
MODEL1112260001: Pathway B 














Figure 1.The underlying mechanisms of ageing. The rate of accumulation of stress-induced random 
molecular damage is dependent on the capacity of the antioxidant system and efficiency of repair 
systems. As these systems are not 100% efficient, cells always contain some unrepaired damage which 
leads to activation of a stress response and upregulation of mechanisms to remove the damage or to 
prevent the cell dividing. However, these responses also become less efficient with age so that damaged 
components accumulate leading to cellular defects which gives rise to tissue dysfunction and ageing 
(adaptation of Kirkwood 2005 (2)).  
Figure 2.The interaction of the molecular mechanisms of ageing. Individual mechanisms cannot explain 
ageing alone, as each mechanism has many interactions. Some example mechanisms and their 
interactions are shown but there are many others which are described in the text.  
Figure 3. A pragmatic classification of modelling frameworks. The first decision concerns whether the 
model must capture the behaviour of the system (Dynamic) or only its structure (Static). Because ageing, 
health and disease are processes, dynamic modelling of biological systems is a common approach within 
computational modelling. The second decision addresses whether the time-evolving behaviour of the 
system can be broken down into discrete states (Discrete) or not (Continuous). Within both of these 
partitions a model can have fixed trajectories for a given parameter set and initial conditions 
(Deterministic) or contain a degree of uncertainty that makes it probabilistic in nature (Stochastic). Within 
both of these approaches one can account for the spatial dimension if deemed appropriate. Examples of 
commonly employed computational frameworks for each classification are shown in blue. Note that the 
development of many frameworks has resulted in the transcending of the traditional classification 
boundaries. Examples include stochastic Boolean networks or dynamic Bayesian networks.  An important 
consideration is how well the biological system can be approximated by a given modelling framework, 
regardless of its underlying fundamental nature. This is exemplified by the Gillespie algorithm, which can 
simulate continuous-deterministic ODE models as discrete-stochastic models given a previous adjustment 
of rate constants and a unit conversion to particle numbers. Another example would be the conversion of 
continuous models from deterministic to stochastic by the addition of a noise factor to the differential 
equations. For a more detailed description of these and other modelling frameworks see (200, 201). Within 
the technical realm, modelling frameworks can be broadly classified into mathematical models, 
algorithmic models and hybrid models (202). 
 
 
 
